ViewTube

Visit VJHemOnc.com to explore the latest updates in the field of multiple myeloma, including updates from COMy, EHA and ASH!

Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, discusses recent updates on the use of CAR-T therapy in ...

Caspian Oliai, MD, MS, University of California, Los Angeles, Los Angeles, CA, discusses the rationale and results of a Phase Ib ...

Kenneth Anderson, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the next steps towards a cure in the myeloma field.

Amer Zeidan, MBBS, Yale University and Yale Cancer Center, New Haven, CT, explores the next questions in acute myeloid ...

Naval Daver, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, explores the use of immuno-oncology in ...

Saad Usmani, MD, FACP, Levine Cancer Institute, Charlotte, NC, is joined by Ajai Chari, MD, PhD, Mount Sinai Medical Center, ...

Jerry Spivak, MD, Johns Hopkins University School of Medicine, Baltimore, MD, shares some insights into the challenges of ...

Kostas Stamatopoulos, MD, PhD, of the Center for Research and Technology Hellas, Thermi, Greece, discusses how a greater ...

David Sallman, MD, Moffitt Cancer Center, Tampa, FL, and Andrew Brunner, MD, Massachusetts General Hospital, Boston, MA, ...

Mark Bustoros, MD, Dana-Farber Cancer Institute, Boston, MA, interviews with VJHemOnc at the International Myeloma Workshop ...

Prithviraj Bose, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares the biggest updates in ...

Paul Hampel, MD, Mayo Clinic, Rochester, MN, presents the findings of a multicenter retrospective study investigating the ...

Pierluigi Porcu, MD, Sidney Kimmel Cancer Center, Philadelphia, PA, comments on the health-related quality of life (HRQoL) data ...

Adrian Wiestner, MD, PhD, National Institutes of Health, Bethesda, MD, discusses results from studies examining the impact of ...

Fewer than 10% of patients with multiple myeloma (MM) are diagnosed during the asymptomatic early stage, known as ...

Preclinical models suggest that markers of liver health before receiving gene therapy for hemophilia may be predictive of the ...

Shirley D'Sa, MD, FRCP, FRCPath, University College London, London, United Kingdom, discusses a study investigating the ...

Emma Searle, MBChB, MA, MRCP, FRCPath, PhD, The Christie NHS Foundation Trust, Manchester, UK, comments on the ...